Cargando…
EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine–immune interactions
EBAG9 has been recently identified as an oestrogen responsive gene in MCF-7 human breast carcinoma cells. EBAG9 is identical to RCAS1, a cancer cell surface antigen possibly involved in immune escape. In this study, we examined the expression of EBAG9/RCAS1 in human breast carcinomas using immunohis...
Autores principales: | Suzuki, T, Inoue, S, Kawabata, W, Akahira, J, Moriya, T, Tsuchiya, F, Ogawa, S, Muramatsu, M, Sasano, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363964/ https://www.ncbi.nlm.nih.gov/pubmed/11742495 http://dx.doi.org/10.1054/bjoc.2001.2176 |
Ejemplares similares
-
Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer
por: Akahira, J-i, et al.
Publicado: (2004) -
Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
por: Reimer, Tatiana A, et al.
Publicado: (2005) -
EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytes
por: Miyazaki, T, et al.
Publicado: (2014) -
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects
por: Wirges, Anthea, et al.
Publicado: (2022) -
Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies
por: Akahira, J, et al.
Publicado: (2000)